• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1960-2019 年法罗群岛的癌症发病情况、死亡率及与其他北欧国家的比较。

Cancer in the Faroe Islands from 1960-2019 - incidence, mortality, and comparisons with the other Nordic countries.

机构信息

Center of Health Science, University of the Faroe Islands, Tórshavn, Faroe Islands.

Medical Department, National Hospital of the Faroe Islands, Tórshavn, Faroe Islands.

出版信息

Acta Oncol. 2022 Aug;61(8):907-915. doi: 10.1080/0284186X.2022.2082885. Epub 2022 Jun 3.

DOI:10.1080/0284186X.2022.2082885
PMID:35657096
Abstract

In this paper, we present age-standardized cancer incidence and mortality rates in the Faroe Islands. We also compare with the Nordic rates and show incidence rate ratios (IRR) and mortality rate ratios (MRR). The Faroese cancer registry (FCR) was established in 1994, with incidence available from 1960 and mortality from 1983. The FCR is a part of the NORDCAN collaboration, where the different Nordic countries all report anonymized cancer data by standardized methods, ensuring comparability. Validation efforts revealed that 13% of cases had not been reported to the FCR from 2006 to 2019, emphasizing the need for continued validation efforts of cancer registries. After validation, we submitted the updated cancer cases to NORDCAN and now present this data, taken directly from the NORDCAN website (2019 data). We found that the incidence of the summary group in the Faroe Islands increased from 1960 to 2019, while cancer mortality decreased from 1983 to 2019. Comparisons with Nordic rates showed significantly lower IRRs for cancer in , , and for both sexes, while IRR was lower for in women and in men. Contrary, IRR was higher for and in women and and in men. There was an increased MRR for cancer in , , and in women, and and cancer in men. In contrast, and in women had a lower MRR. Cancer incidence in the Faroe Islands was lower than in the other Nordic countries. Of particular interest, the incidence of testicular cancer saw a steep increase during the last 20 years, and an investigation into possible causes for this is needed.

摘要

本文呈现了法罗群岛的年龄标准化癌症发病率和死亡率。我们还将其与北欧国家的数据进行了比较,并展示了发病率比值(IRR)和死亡率比值(MRR)。法罗群岛癌症登记处(FCR)成立于 1994 年,发病率数据可追溯到 1960 年,死亡率数据可追溯到 1983 年。FCR 是 NORDCAN 合作组织的一部分,其中不同的北欧国家均按照标准化方法报告匿名癌症数据,以确保数据的可比性。验证工作表明,2006 年至 2019 年期间,有 13%的病例未向 FCR 报告,这强调了癌症登记处需要持续进行验证工作。在验证后,我们向 NORDCAN 提交了更新后的癌症病例,并现在直接从 NORDCAN 网站(2019 年数据)呈现这些数据。我们发现,法罗群岛的汇总组癌症发病率从 1960 年增加到 2019 年,而癌症死亡率从 1983 年下降到 2019 年。与北欧国家的数据比较显示,男性和女性的癌症发病率均显著较低,而女性的发病率较低,男性的发病率则较低。相反,女性的发病率较高,男性的发病率也较高。女性的癌症死亡率有所增加,而男性的死亡率则有所增加。相反,女性的癌症死亡率则有所降低。法罗群岛的癌症发病率低于其他北欧国家。特别值得注意的是,过去 20 年来,睾丸癌的发病率急剧上升,需要对此进行调查以确定其可能的原因。

相似文献

1
Cancer in the Faroe Islands from 1960-2019 - incidence, mortality, and comparisons with the other Nordic countries.1960-2019 年法罗群岛的癌症发病情况、死亡率及与其他北欧国家的比较。
Acta Oncol. 2022 Aug;61(8):907-915. doi: 10.1080/0284186X.2022.2082885. Epub 2022 Jun 3.
2
Cancer survival in the Faroe Islands over the last 50 years compared to the other Nordic countries.过去50年法罗群岛的癌症生存率与其他北欧国家的比较。
Int J Cancer. 2023 May 15;152(10):2090-2098. doi: 10.1002/ijc.34456. Epub 2023 Feb 13.
3
Time trends and occupational variation in the incidence of testicular cancer in the Nordic countries.北欧国家睾丸癌发病率的时间趋势和职业差异。
BJU Int. 2018 Sep;122(3):384-393. doi: 10.1111/bju.14148. Epub 2018 Mar 1.
4
Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019.1990年至2019年北欧国家膀胱癌和上尿路尿路上皮癌患者的发病率、死亡率及相对生存率。
Scand J Urol. 2023 Feb-Dec;57(1-6):15-21. doi: 10.1080/21681805.2022.2138965. Epub 2022 Nov 23.
5
NORDCAN--a Nordic tool for cancer information, planning, quality control and research.NORDCAN——一个北欧癌症信息、规划、质量控制和研究工具。
Acta Oncol. 2010 Jun;49(5):725-36. doi: 10.3109/02841861003782017.
6
Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016: The NORDCAN survival studies.1990-2016 年北欧国家诊断为皮肤恶性黑色素瘤患者的生存趋势:NORDCAN 生存研究。
Eur J Cancer. 2024 May;202:113980. doi: 10.1016/j.ejca.2024.113980. Epub 2024 Mar 1.
7
Birthweight and gestational age in the Faroe Islands: A comparison between birthweight and gestational age in the Faroe Islands and other Nordic countries.法罗群岛的出生体重和胎龄:与其他北欧国家相比,法罗群岛的出生体重和胎龄。
Acta Obstet Gynecol Scand. 2023 Apr;102(4):506-515. doi: 10.1111/aogs.14527. Epub 2023 Feb 15.
8
Survival trends in patients diagnosed with colon and rectal cancer in the nordic countries 1990-2016: The NORDCAN survival studies.北欧国家 1990-2016 年确诊结肠癌和直肠癌患者的生存趋势:NORDCAN 生存研究。
Eur J Cancer. 2022 Sep;172:76-84. doi: 10.1016/j.ejca.2022.05.032. Epub 2022 Jun 24.
9
Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006.北欧国家 1964-2003 年间诊断为肾或膀胱癌患者的生存趋势,随访至 2006 年底。
Acta Oncol. 2010 Jun;49(5):655-64. doi: 10.3109/02841860903575299.
10
Trends in cancer survival in the Nordic countries 1990-2016: the NORDCAN survival studies.北欧国家 1990-2016 年癌症生存趋势:NORDCAN 生存研究。
Acta Oncol. 2020 Nov;59(11):1266-1274. doi: 10.1080/0284186X.2020.1822544. Epub 2020 Oct 19.

引用本文的文献

1
Sex Differences in Lung Cancer Characteristics at Diagnosis: A Nationwide Register-Based Study From the Faroe Islands (2015-2020).肺癌诊断特征中的性别差异:来自法罗群岛的一项基于全国登记的研究(2015 - 2020年)
Cancer Rep (Hoboken). 2025 Jan;8(1):e70066. doi: 10.1002/cnr2.70066.
2
Childhood cancer incidence and survival in the Faroe Islands, 1960 to 2019.法罗群岛儿童癌症发病和生存情况,1960 年至 2019 年。
Acta Oncol. 2024 Feb 8;63:4-8. doi: 10.2340/1651-226X.2024.27110.